Contact us


    Collection and Use of Personal Information. *


    At Deep Bio, we're at the forefront of transforming drug discovery through harnessing the full potential of data and AI. Our AI-enabled drug discovery solutions help guide biopharmaceutical companies in their quest to bring new drugs to market. DeepCDx combines state-of-the-art AI technology with a client-driven approach to develop purpose-built diagnostic solutions that accelerate the pace of discovery and drive innovation.

    To Learn More Download

    Advanced deep
    learning technology
    to provide unmatched

    Core Technology that sets us apart

    Our patented methods have been trained on thousands of cases to yield instantaneous and precise analysis of data.

    World-class patents in:
    • 01

      Deep learning-based diagnostics

    • 02

      Diagnostic result visualization

    • 03

      Tissue slide indexing technology

    • 04

      Intelligent annotation technology

    Awards & Recognition

    • Edison Awards - Silver

      DeepDx Prostate won Silver at the Edison Award 2021 in the Cellular Research & Disease Prevention category.

    • Camelyon17 Grand Challenge

      Our research team won the first place in Camelyon17, a global image analysis competition for detection and classification of breast cancer lymph nodes metastasis.

    R&D to innovate medical AI

    AI-based Predictive Analytics
    in Cancer Pathology

    Development of prediction models by combining cancer pathology image analysis with oncology clinical data.


    DeepDx® Prostate is CE-marked, and MFDS-approved for clinical use in Korea. DeepDx® solutions are not cleared by the FDA and for Research Use Only (RUO) in the United States. Contact Deep Bio for more information on system configuration, functionality and indications for use.